Skip to content
Home/Companies/Healthcare/Hemerion Therapeutics
Hemerion Therapeutics

Hemerion Therapeutics

Healthcare·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Hemerion Therapeutics?

Hemerion Therapeutics is currently owned by Finovam Gestion through FIRA Nord-Est 2 (2021 vintage), since 2022.

Hand-verified · updated 2026-04-21

Finovam Gestion
Investor
Finovam Gestion
FIRA Nord-Est 2 · 2021 · VC

Key facts

HQFrance
SectorHealthcare
Websitehemerion.com

More from FIRA Nord-Est 2

Other portfolio companies in the same fund.

Surgitec Robotics
Active
MedTechFrance· 2026
Dianosic
Active
MedTechFrance· 2025
Mariloo
Active
ConsumerFrance· 2025
PikkoPay
Active
FintechFrance· 2025
StemInov
StemInov
Active
BiotechFrance· 2025
Cellaven
Cellaven
Active
MedTechFrance· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Hemerion Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Hemerion Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue